When the Covid-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people - but in the background there was ...

UConn Health and Connecticut Children's have made history by dosing the first patient in a clinical trial using gene editing to treat glycogen storage ...

A new industry-born initiative aims to stimulate innovation in the agri-food sector in a way that is beneficial to both small ...

The future of sustained space habitation depends on our ability to grow fresh food away from Earth. The revolutionary new ...

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

Learn about the Moon-Rice project, which aims to create rice crops that can grow in space and help keep astronauts healthy.

It’s time to step up the opposition to designer babies, says Marcy Darnovsky of the Center for Genetics and Society ...

CZI and the IGI announce the funding of the Center for Pediatric CRISPR Cures to use CRISPR-based editing technology to advance cures.

CRISPR Therapeutics AG CRSP shares rallied 9.6% in the last trading session to close at $60.08. This move can be attributable to notable volume with a higher number of shares being traded than in a ...

CRISPR technology is transforming modern medicine by enabling precise DNA editing to treat genetic disorders, including sickle cell anemia and beta-thalassemia, experts say.